Asahi Kasei Profits Surge 50.6 Percent Supply Adjustment in Semiconductor Materials Sparks Concerns
Japanese giant Asahi Kasei reported impressive financial results for the 2024-2025 fiscal year ending March 2025. The company achieved 211.9 billion yen in operating profit, a 50.6% increase from the previous year, marking its highest level in six years. Sales revenue reached 3.0373 trillion yen, up by 9.1%, while recurring profit soared by 114.7% to 193.4 billion yen. Net profit also surged by 208.2%, hitting 134.9 billion yen.
Analysts attribute the growth to strong performance in medical devices and semiconductor materials, alongside the company’s pricing strategy that links material costs to petrochemical raw material prices, driving profitability across all divisions.
In May, Asahi Kasei’s announcement of supply adjustments in its PIMEL series of high-end photosensitive materials, including photosensitive polyimide (PSPI), caused ripples in the semiconductor industry. The surge in AI demand has outstripped production capacity, raising fears of supply disruptions in advanced packaging materials.
Asahi Kasei issued a statement to clarify the situation, emphasizing that demand for PIMEL has exceeded expectations, driven by growing interest in advanced semiconductor packaging technologies. The company denied rumors of a supply halt, stating, "This is not true." It assured that production remains stable, supported by a new factory in Shizuoka Prefecture that began operations in December 2024. Additionally, discussions with clients are ongoing to ensure continuous supply, and plans for long-term capacity expansion are under consideration.
Although the supply disruption was a false alarm, the incident highlighted the critical role of PSPI in semiconductor manufacturing and underscored the risks in global supply chains, prompting a renewed push for domestic alternatives in China.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
Lotte Chemical Plans Sale of Selected Operations in Malaysia, Indonesia, and the United States
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant
Recommend Reading
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Solar Industries Offers $1.355 Billion for South Africa’s Omnia in Global Mining Chemicals Expansion
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Premium Global Chemical Sourcing Requests (9-13July, 2026)
-
Business Society October 15, 2026 Melamine Trend Analysis: Weakness-Driven Rebound
-
Business Society’s Trend Analysis for Fuel Oil 180CST on September 14, 2026: Volatile Fluctuations
-
Business Society October 15, 2026 Ethanol Trend Analysis: Strong Consolidation
-
Premium Global Chemical Sourcing Requests (23-26Apr, 2026)